Research group takes on very early signs of Alzheimer’s
Canterbury research group takes on very early signs of Alzheimer’s disease
Where did I put my keys? What did I come to the supermarket for? Where did I park the car? What have I done with my phone?
They’re common signs of absent-mindedness that most of us think nothing of. Often, forgetting the little things can just be a symptom of a busy lifestyle and not a cause for concern.
In some cases though, it’s small things like these that herald a condition known as “early memory loss” – one of the first signs of Alzheimer’s disease.
CGM Research Trust, a well-recognised medical research organisation, is tackling early memory loss head on – trialling a new investigational medication that could help slow the progression of the disease.
CGM Research Trust Trustee and Investigator Dr Nigel Gilchrist is excited about the prospect of the new medication and what it could potentially mean for preventing the onset of early memory loss.
“Currently available medications work at managing the symptoms of memory loss but do not necessarily slow the course of the disease. The medication we are trialling potentially does this. If it works it would be an exciting breakthrough.”
To be eligible for the trial, participants need to be aged between 50-70, live in Canterbury and have somebody who can bring them to appointments, amongst other criteria.
More information about the trial can be found at: www.remembertheelephant.co.nz